The control of gene expression by miRNAs has been widely investigated in different species and cell types. Following a probabilistic rather than a deterministic regimen, the action of these short nucleotide sequences on specific genes depends on intracellular concentration, which in turn reflects the balance between biosynthesis and degradation. Recent studies have described the involvement of XRN2, an exoribonuclease, in miRNA degradation and PAPD4, an atypical poly(A) polymerase, in miRNA stability. Herein, we examined the expression of XRN2 and PAPD4 in developing and adult rat hippocampi. Combining bioinformatics and real-time PCR, we demonstrated that XRN2 and PAPD4 expression is regulated by the uncorrelated action of transcription factors, resulting in distinct gene expression profiles during development. Analyses of nuclei position and nestin labeling revealed that both proteins progressively accumulated during neuronal differentiation, and that they are weakly expressed in immature neurons and absent in glial and endothelial cells. Despite the differences in subcellular localization, both genes were concurrently identified within identical neuronal subpopulations, including specific inhibitory interneurons. Thus, we cope with a singular circumstance in biology: an almost complete intersected expression of functional-opposed genes, reinforcing that their antagonistically driven actions on miRNAs "make sense" if simultaneously present at the same cells. Considering that the transcriptome in the nervous system is finely tuned to physiological processes, it was remarkable that miRNA stability-related genes were concurrently identified in neurons that play essential roles in cognitive functions such as memory and learning. In summary, this study reveals a possible new mechanism for the control of miRNA expression.
. Regulation of gene expression by miRNAs is highly conserved among species, and has been studied in a wide variety of processes and cell types (Matzke and Matzke, 2004) .
In the nervous system, the role of miRNAs has also been investigated in fundamental processes such as development (Decembrini et al., 2009; Gao, 2008; Li et al., 2011; Sanuki et al., 2011; Somel et al., 2011) , cell differentiation (Andersson et al., 2010; Zheng et al., 2010) , adaptation to ambient demands (Bredy et al., 2011; Konopka et al., 2011; Krol et al., 2010) , neurodegeneration, and other disorders (Eacker et al., 2009; Harraz et al., 2012; Xu et al., 2013) . During hippocampal formation, changes in miRNA expression govern synaptic plasticity (Cohen et al., 2011; Lee et al., 2012) such as memory and learning (Konopka et al., 2011; Wang et al., 2012) . Following a probabilistic rather than deterministic operandi (Ragan et al., 2011) , miRNA specificity depends on its cytosolic concentration, which in turn is the result of the balance between biosynthesis and degradation. While mechanisms underlying miRNA synthesis have been exhaustively investigated (Diederichs and Haber, 2007; Koscianska et al., 2011; Wu et al., 2012) , little is known about proteins involved in miRNA stability and degradation (Bail et al., 2010) . Recent studies have described the involvement of XRN2, a 5′ → 3′ exoribonuclease, in miRNA degradation and PAPD4, an atypical poly(A) polymerase also known as GLD-2, in miRNA stability (Kai and Pasquinelli, 2010; Katoh et al., 2009) .
In this study, we thoroughly examined the ontogenesis of XRN2 and PAPD4 in hippocampal neurons, progenitor, glial, and endothelial cells using a combination of different methods and analyses. Studies employing hippocampal formation include several advantages such as a constant cell proliferation state, synaptic plasticity, and neuronal diversity in well-characterized neuronal circuits. We demonstrate that genes with antagonist driven-actions on miRNAs may represent an additional mechanism in the control of the transcriptome.
Material and methods

Ethics statement
Experiments with animals were conducted in accordance with guidelines of the National Institute of Health and the Brazilian Society for Laboratory Animals. The experimental protocol was approved by the Ethics Committee in Animal Experimentation of the Institute of Biomedical Sciences/University of São Paulo (ICB/USP).
Animal procedures
Experiments were carried out with Long Evan rats (Rattus norvegicus) kept on a 12 h light/dark cycle with lights on at 06:00 a.m. Embryonic day 21 (E21) and postnatal day 5 (P5), P10 and P60 rats were euthanized with an overdose of ketamine (30 mg/100 g of body weight, i.m., Parke-Davis, Ann Arbor, MI, USA) and xylazine (2 mg/100 g, i.m., West Haven, CT, USA) between 10:00 and 12:00 a.m. Following euthanasia, their hippocampi were dissected for different methodologies.
Transcription factor binding site analysis
Transcription factor binding sites (TFBS) were analyzed using Mapper2 software (Marinescu et al., 2005) . After identifying putative transcription factors, they were categorized on the basis of the score and E-value parameters. The score is the logarithm to the base 2 of the ratio P(seq|HMM)/P(seq|null), where P(seq|HMM) is the probability of the target sequence according to the HMM model and P(seq|null) is the probability of the sequence according to a null model distribution. Therefore, the greater the score, the better is the match between the hit and the model. In contrast, the E-value is based on the number of sequences queried in the database and is a measure of the expected number of false positives that will have scores equal to or greater than the score of the hit. The smaller the E-value, the more significant is the hit.
RNA isolation, cDNA synthesis and real-time PCR
The HIPPOCAMPI were directly homogenized in 1-1.5 ml of a TRIzol reagent (Invitrogen, Carlsbad, CA, USA) and total RNA was extracted following the manufacturer protocol and previously described procedures (Kihara et al., 2005; Paschon et al., 2012) . Briefly, following two chloroform extraction steps, RNA was precipitated with isopropanol and the pellet washed twice in 70% ethanol. After air-drying, RNA was resuspended in DEPC-treated water and the concentration of each sample obtained from A 260 measurements. Residual DNA was removed using DNase I (Amersham, Piscataway, NJ, USA) following the manufacturer protocol. Quantitative analysis of gene expression was carried out with a Rotor-Gene 6000 real-time rotary analyzer (Corbett Robotics Inc., San Francisco, CA, USA) with specific primers for rat XRN2 (forward, 5′-TCGAGGAGGGCGACAGGGAT-3′; reverse, 5′-GGGCGGTGGCA AAGGGTACT-3′) and rat PAPD4 (forward, 5′-ACAGGGTTGTCTACGCCG CC-3′; reverse, 5′-CGCGGGCGTGTTAAGTTGGG-3′). cDNA abundance for cyclophilin A (forward, 5′-GCGTTTTGGGTCCAGGAATGGC-3′; reverse, 5′-TTGCGAGCAGATGGGGTGGG-3′) was determined as an internal control. For each 20 μl reverse transcription reaction, 4 μg of total RNA was mixed with 1 μl of oligo-dT primer (0.5 μg; Invitrogen) and incubated for 10 min at 65°C. After cooling on ice the solution was mixed with 4 μl of 5× first strand buffer, 2 μl of 0.1 M DTT, 1 μl of dATP, dTTP, dCTP and dGTP (each 10 mM), and 1 μl of SuperScript III reverse transcriptase (200 U; Invitrogen) and incubated for 60 min at 50°C. Reaction was inactivated by heating at 70°C for 15 min. All PCR assays were performed as follows: after initial activation at 50°C for 2 min and 95°C for 10 min, cycling conditions were 95°C, 10 s and 60°C, 1 min. Dissociation curves of PCR products were obtained by heating samples from 60 to 95°C, in order to evaluate primer specificity.
PCR statistical analysis
Relative quantification of target gene expression was evaluated using the comparative CT method as previously described in detail (Kihara et al., 2008b; Medhurst et al., 2000) . In the present study, we considered P60 animals as the control group. Values were entered into one-way analysis of variance (ANOVA), followed by pairwise comparisons in Tukey's HSD test, with the significance level set at 5%.
Western blotting
The hippocampi were rapidly dissected, washed with phosphate buffered saline (PBS), and homogenized in a RIPA buffer (50 mM Tris, 150 mM NaCl, 0.1% SDS, 0.5% sodium deoxycholate, 1% Triton X-100, and protease inhibitors). Homogenates were centrifuged for 20 min at 14,000 g and 4°C to remove insoluble material. Protein concentration was determined using the BCA method (Thermo Scientific, Rockford, IL, USA, catalog # 23225), and bovine serum albumin was used as the standard as per the manufacturer's instructions. Proteins in the membrane preparations were separated using sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE; 10% gel) and transferred onto nitrocellulose membranes (Santos-Bredariol et al., 2006) . Blots were incubated with 5% non-fat milk in a TBST buffer for 2 h at room temperature to block nonspecific binding of antibodies. After rinsing the blots with TBST, they were incubated overnight with primary antibodies against XRN2, PAPD4, and beta-actin diluted in TBST/3% non-fat milk (Table 1) . After incubation with primary antibodies, blots were rinsed with TBST and incubated with goat anti-rabbit peroxidase (ECL™ kit; Amersham, Buckinghamshire, England) for 2 h at room temperature. Detection of labeled proteins was achieved by using the enhanced chemiluminescent system (ECL™ kit; Amersham). The optical band densities (OBDs) were determined using ImageJ software (National Institute of Mental Health, Bethesda, Maryland, USA). OBDs were normalized against protein levels expressed in the adult hippocampus. Data from four independent experiments were analyzed using one-way ANOVA with repeated measures, followed by pairwise comparisons with Tukey's HSD test.
Immunohistochemistry
Brains were collected and fixed for 8 h in 1% paraformaldehyde (PFA) in phosphate buffered saline (PBS; 0.1 M, pH 7.3), and cryoprotected in a 30% sucrose solution for at least 48 h at 4°C. After embedding the brain in an Optimum Cutting Temperature compound (OCT, Sakura Finetek USA, Inc., Torrance, CA, USA), coronal sections (12 μm) were obtained on a Leica CM1850 cryostat (Leica Microsystems Inc., IL, USA). Brain sections containing the hippocampus were incubated overnight with primary antibodies in a solution containing 5% normal goat serum and 0.3% Triton X-100 in PBS at room temperature. All the antibodies and specific concentrations used in this study are listed in Table 1 . After several washes, brain sections were incubated with a goat antiserum against rabbit IgG tagged to Alexa 488 (1:200-1:500, Invitrogen) diluted in 0.3% Triton X-100 in PBS for 2 h at room temperature. For double-labeling experiments, we employed secondary antibodies conjugated to Alexa 546 and Alexa 647 (1:200-1:500, Invitrogen). Controls for the experiments consisted of the omission of (E) Amplification plots of hippocampal samples obtained from 21-day-old embryos (E21, red) and adult rats (P60, green) using primers designed for XRN2. E21 samples required fewer cycles for visualization of the amplification plot compared with P60 samples. (F) Dissociation curves of the first derivative plot from normalized fluorescence of amplicons generated by XRN2 primers against temperature. The melting temperature (Tm) of PCR products (indicated by the peak of the solid line) exactly matched the theoretical Tm expected for the amplicon. (G, H) Amplification plots and dissociation curves from E21 (red) and P60 (green) cDNA samples using PAPD4 primers. E21 and P60 samples have similar amplification plots. (I) XRN2 expression during hippocampal development normalized to the control at P60. We observed higher expression levels at E21, P5, and P10 than those at P60. (J) PAPD4 expression during hippocampal development normalized by P60. We observed higher transcript levels at P5 than those at P60. Cyclophilin A expression was used as an internal control. Bars represent standard errors of the mean. *P b 0.05, **P b 0.01, ***P b 0.001 vs. P60 in Tukey's HSD pairwise comparisons after one-way ANOVA. Beta-actin (42 kDa) was used as an internal control. Optical band densities (OBD) at E21, P5, and P10 were normalized against the OBD at P60 (adult) in three independent experiments (n = 4). (B) We observed that XRN2 protein levels decreased at E21, P5, and P10 compared with those at P60. (C) In contrast, we observed lower PAPD4 protein levels at E21, P5, and P10 than those at P60. *P b 0.001, **P b 0.01 vs. P60 in Tukey's HSD pairwise comparisons after one-way ANOVA. primary antibodies; no staining was observed in these cases. Counterstaining of brain sections was achieved using 4′,6-diamidino-2-phenylindole (DAPI). After washing, the specimen was mounted using Vecta Shield (Vector Labs, Burlingame, CA, USA), and analyzed with a Nikon TS100F inverted microscope (Nikon Instruments Inc., Melville, NY, USA). Figures were mounted with Adobe Photoshop CS5. Manipulation of the images was restricted to brightness and contrast adjustments of the whole image.
Image quantification
Image analysis was performed with ImageJ software (National Institute of Mental Health, Bethesda, Maryland, USA) and NIS-elements AR 3.2 64-bit software (Nikon Instruments Inc.), as previously described (Kihara et al., 2008a) . After channel separation (RGB) of the color images, we performed quantification of the mean pixel intensity, where values correspond to the brightness of the pixels of delimited areas corresponding to the cell nuclei. Each value was normalized by the mean pixel intensity of all labeled cells in the same image. In some cases, areas of interest (AOIs) were defined by the labeling in one channel, and analysis was performed in another channel, as for instance, labeling of XRN2 and PAPD4 in the green channel, defined by DAPI labeling in the blue channel. Pearson's correlation between PAPD4 and DAPI was performed employing 6-8 hippocampal slices of 3 animals at ages E21 and P60. The coefficients provided by each analysis were used to calculate the mean of Pearson's correlation in E21 and P60 Fig. 3 . XRN2 immunolabeling in developing and adult rat hippocampi. XRN2 (green) immunolabeling in coronal sections of developing and adult hippocampi followed by counter-staining with 4′,6-diamidino-2-phenylindole (DAPI, blue). (A-H) XRN2 immunoreactivity in the CA1 region was observed in pyramidal cell nuclei and in some cells within strata oriens, radiatum, and lacunosum-moleculare in developing and adult hippocampi. (I-P) In the CA3 region of the hippocampus in all studied ages, XRN2 labeling was also observed in pyramidal cell nuclei and in strata oriens, radiatum, and lacunosum-moleculare. In the dentate gyrus, XRN2 immunolabeling at E21 (Q, U) was detected in cells located predominantly in the hilus, with extremely sparse staining in the granule cell layer. At P5 (R, V), XRN2 labeling was clearly detected in the granule cell layer. At P10 (S, T) and P60 (W, X), XRN2-positive cells were observed both in the hilus and granule cell layer. Scale bar: 50 μm.
hippocampi. Values were exported to Excel (Microsoft, Redmond, WA, USA) or Statistica (StatSoft, Tulsa, OK, USA) for the appropriate statistical analysis. Images and charts were prepared with Adobe Photoshop CS5 (Adobe Systems Inc., San Jose, CA, USA).
Results
XRN2 and PAPD4 transcription is specifically regulated, resulting in distinct gene expression profiles during development XRN2 and PAPD4 genes are located on distinct chromosomes, and have different lengths (3787 vs. 1871 bp) but similar open reading frames (1685 and 1454 bp, respectively). Using bioinformatics, we defined transcription factor binding sites (TFBS) located as far as 2000 bp upstream, which would be under the control of 194 different transcription factors. From these, we verified that only 24 transcription factors may regulate both XRN2 and PAPD4. We plotted these 24 TFBS according to their score and E-value parameters, which estimate the probability of a given factor to regulate gene transcription at a specific DNA binding site (Marinescu et al., 2005 ). Pearson's correlation analyses revealed coefficient values extremely close to zero for both parameters. Taken together, these results indicated that XRN2 and PAPD4 are most probably not regulated by common transcription factors (Figs. 1, A-D) . . PAPD4 immunolabeling in the developing and adult rat hippocampi. PAPD4 (green) immunolabeling of the developing and adult rat hippocampi, counter-stained with DAPI (blue). PAPD4 immunostaining in the CA1 region of the hippocampus at E21 (A, E) was observed primarily in the cytosol of pyramidal cells, and also in strata oriens, radiatum, and lacunosummoleculare. At P5 (B, F) and P10 (C, G), PAPD4 progressively accumulates in nuclei, whereas at P60 (D, H), a clear nuclear labeling in pyramidal cells was observed in addition to a few positive cells in strata oriens, radiatum, and lacunosum-moleculare. (I-P) In the CA3 region, we observed similar changes in PAPD4 subcellular distribution during development i.e., a progressive accumulation of the protein in cell nuclei. In the dentate gyrus (DG), PAPD4 labeling at E21 (Q, U) was primarily seen in the cytosol of cells located in the hilus, with weak staining in the granule cell layer. At P5 (R, V) and P10 (S, W), an increase in PAPD4 in the granule cell layer was detected, and in hilar cells, we observed a progressive accumulation of PAPD4 in nuclei. (T, X) In the DG at P60, PAPD4 immunoreactivity was observed in cells located within the granule cell layer and hilus. Scale bar: 50 μm.
Using primers specifically designed for XRN2 and PAPD4, we generated amplification plots from cDNA serial dilutions. Dissociation curves of these PCR products were obtained by heating samples from 60°C to 95°C. A single peak was observed and found to match the theoretical melting temperature previously calculated, indicating specificity of the primers. Amplification plots indicated that XRN2 expression was higher at E21 than at P60, whereas PAPD4 showed no significant differences in transcript levels at both ages (Figs. 1, E-H).
We observed XRN2 and PAPD4 transcripts to have distinct expression profiles and that they are expressed at all developmental ages investigated in this study. Our results indicated that XRN2 expression was higher in the hippocampus at E21 (2^1.29 = 2.45-fold-expression, P b 0.001), P5 (2^1.01 = 2.02-fold-expression, P b 0.001), and P10 (2^0.60 = 1.51-fold-expression, P b 0.01) than at P60. In contrast, our results indicated that PAPD4 expression peaked at P5 (2^0.53 = 1.44-fold-expression, P b 0.05), and it remained stable at the other developmental ages studied, similar to P60 (Figs. 1, I -J). In these PCR experiments, cyclophilin expression was used as an internal control (data not shown).
XRN2 and PAPD4 have distinct protein levels during hippocampal development
Because XRN2 and PAPD4 transcripts were present in the developing and adult hippocampi, we subsequently examined whether these genes are actually translated into proteins. We were able to detect these proteins, and they appeared to be specifically regulated during hippocampal development (Fig. 2A) . We observed the XRN2 protein level to match the gene expression profile previously shown. The XRN2 protein level was higher in the hippocampus at E21 (919%, P b 0.001), P5 (860%, P b 0.001), and P10 (720%, P b 0.001) than at P60 (Fig. 2B) . In contrast, the PAPD4 protein level was different from its gene expression profile during hippocampal development. A lower level of PAPD4 was detected at E21 (53%, P b 0.01), P5 (38%, P b 0.001), and P10 (51%, P b 0.01) than at P60 (Fig. 2C ).
XRN2 and PAPD4 share a similar distribution pattern in the developing and adult hippocampi
Immunohistochemistry was employed to examine the spatial distribution of XRN2 in the developing and adult hippocampi. XRN2 labeling was predominantly detected in cell nuclei with sporadic cytosolic staining. At E21, XRN2 labeling in CA1 and CA3 regions was mostly observed in the pyramidal cell layer and in some cells within the strata oriens, radiatum, and lacunosum-moleculare. In the dentate gyrus (DG), XRN2-positive cells were predominantly seen in the hilus, with extremely sparse labeling in the granule cell layer, which is mostly formed by immature neurons from E17 to a few weeks after birth (Fig. 3, first  column) . At P5, the distribution pattern of XRN2 in the CA1 and CA3 regions was maintained. However, we observed labeling in the granule cell layer of the DG (Fig. 3, second column) . At P10 and P60, XRN2 immunolabeling in the CA1 and CA3 regions was similar to that observed in the P5 hippocampus, with nuclear staining of pyramidal cells and a few XRN2-positive nuclei in the strata oriens, radiatum, and lacunosum-moleculare. XRN2-positive cells were observed both in the hilus and granule cell layer of the DG (Fig. 3, third and fourth  columns) .
We observed a similar pattern of PAPD4 distribution in the hippocampus, although changes in its subcellular localization were observed during development. At E21, PAPD4 labeling was mainly cytosolic within pyramidal cells and also in the strata oriens, radiatum, and lacunosummoleculare within CA1 and CA3 regions (Fig. 4, first column) . A similar labeling pattern was observed in the hilus, with weak staining in the granule cell layer. In the P5 and P10 hippocampi (Fig. 4 , second and third columns) we observed a progressive accumulation of PAPD4 in the nuclei of cells located within the CA1 and CA3 regions. In the DG, we detected an obvious increase in PAPD4 in the granule cell layer and a gradual increase in the nuclei of hilar cells. At P60, we observed nuclear labeling in pyramidal cells within the CA1 and CA3 regions. A few positive cells in the strata oriens, radiatum, and lacunosum-moleculare were also observed. In addition, PAPD4-positive labeling was observed in the granule cell layer and hilus (Fig. 4, fourth column) . 
XRN2 and PAPD4 are weakly expressed in immature neurons
Since XRN2 and PAPD4 were detected in the developing hippocampus, we subsequently examined whether these proteins are also present in immature neurons. For this purpose, we performed double-labeling experiments in the E21 hippocampus using nestin, a marker for neural progenitor cells (Frederiksen and McKay, 1988) . Nestin is an intermediate filament protein; therefore, nuclei surrounded by this marker were used to identify nestin-positive cells and used for the quantification of mean pixel intensity (n = 4). We observed that nestin-positive cells displayed extremely low levels of XRN2 (Figs. 5, A-E) labeling compared with nestin-negative cells (0.17 ± 0.04 vs. 1.36 ± 0.09, P b 0.001). Similar results were observed for PAPD4 (Figs. 5, F-J) in nestin-positive compared with that in nestin-negative cells (0.3 ± 0.06 vs. 1.43 ± 0.06, P b 0.001).
XRN2 and PAPD4 progressively accumulate in neuronal nuclei
To confirm our results that both XRN2 and PAPD4 accumulate in mature neurons, we assessed the presence of these proteins during neuronal differentiation. We followed the migration route of cells towards their definitive location, a phenomenon occurring simultaneously with neuronal differentiation (Fig. 6A ). XRN2 expression appeared to increase during neuronal maturation. We observed this gradual, differential labeling in the CA3 region at different time points during hippocampal development (Figs. 6, B-E) .
We quantified the mean pixel intensity (n = 3) of pyramidal cells located near the suprapyramidal region and adjacent to the infrapyramidal region (Figs. 6, F-H). XRN2 labeling was significantly higher in the suprapyramidal segment of the CA3 pyramidal layer than in the infrapyramidal segment in E21 (1.2 ± 0.05 vs. 0.66 ± 0.04, P b 0.01) and P5 (1.3 ± 0.06 vs. 0.67 ± 0.08, P b 0.01) hippocampi. In contrast, we did not observe significant changes at P60 (Figs. 6, I-N) .
Based on the changes observed in PAPD4 labeling during hippocampal development i.e., the translocation of this protein from the cytosol to the nucleus, we aimed to analyze this phenomenon in the E21 and P60 hippocampus (Fig. 7) . After combining pixel intensity profiles and digital zooming with RGB decomposition data from E21 (Figs. 7, A-D) and P60 (Figs. 7, E-H) hippocampi, we observed PAPD4 to transit from the cytosol to nucleus. Mean values from Pearson's analysis (n = 3) revealed no spatial correlation between DAPI and PAPD4 signals at E21 (−0.008 ± 0.07), indicating a cytosolic distribution of the protein at this age. Nevertheless, a strong correlation between DAPI and PAPD4 was observed (0.67 ± 0.02) in the P60 hippocampus, suggesting a predominantly nuclear localization. Statistical significance was obtained (P b 0.01), which revealed that PAPD4 translocates from the cytosol to the nucleus as development progresses (Figs. 7, I -K).
XRN2 and PAPD4 are virtually absent in glial and endothelial cells
Considering that XRN2 and PAPD4 accumulate along with neuronal differentiation, we subsequently evaluated whether these proteins are also expressed in other differentiated cells. Double-labeling experiments using anti-GFAP (Figs. 8 and 9 ) and anti-eNOS (Fig. 10) were performed to determine whether these proteins are expressed in glial and endothelial cells, respectively.
Mean pixel intensity analyses (n = 3) performed at P5 (Figs. 8, A-E) and P60 (Figs. 8, F-J) revealed XRN2 to be almost nearly absent in GFAPpositive cells compared with that in GFAP-negative cells, both at P5 (0.31 ± 0.05 vs. 1.53 ± 0.08, P b 0.001) and P60 (0.37 ± 0.03 vs. 1.54 ± 0.11, P b 0.001). Similar results were observed for PAPD4 at P5 (Figs. 9, A-E) and P60 (Figs. 9, F-J), in GFAP-positive and GFAPnegative cells at P5 (0.22 ± 0.004 vs. 1.51 ± 0.03, P b 0.001) and P60 (0.33 ± 0.04 vs. 1.5 ± 0.05, P b 0.001).
In coronal P60 hippocampal sections, eNOS-labeled vessels were observed in all regions analyzed along with endothelial cells with typical elongated nuclei. Experiments using anti-eNOS (n = 4) revealed that both XRN2 (Figs. 10, A-D) and PAPD4 (Figs. 10, E-H) do not accumulate in endothelial cells.
XRN2 and PAPD4 accumulate in calretinin-containing hippocampal interneurons
After we determined the presence of XRN2 and PAPD4 in differentiated and mature neurons, we subsequently investigated in which specific neuronal subpopulations of the adult hippocampus these proteins were expressed. For this purpose, we performed double-labeling experiments using anti-calretinin (CR), a calcium binding protein that is mostly present in interneurons specializing in the control of other GABAergic interneurons (Gulyas et al., 1996) , the so-called interneuronspecific interneurons (Chamberland and Topolnik, 2012) . We could observe that CR-positive neurons in CA1, CA3, and DG regions are labeled with both XRN2 (Figs. 11, A-E) and PAPD4 (Figs. 11, F-J) . After combining the pixel intensity profiles and digital zooming followed by RGB decomposition data from the CA1 region, we indicated that XRN2 and PAPD4 are present in those cells. Moreover, quantification of pixel intensities (n = 3) revealed the labeling of XRN2 (0.95 ± 0.25 vs. 0.96 ± 0.07) and PAPD4 (1.08 ± 0.24 vs. 0.84 ± 0.11) to be similar between CRpositive and -negative cells. In both cases, no significant differences were observed using paired t test.
PAPD4 is highly expressed in interneurons that are specifically responsible for regulating the input integration of pyramidal cells
To further examine the expression of XRN2 and PAPD4 in specific neuronal subpopulations, we conducted double-labeling experiments using anti-parvalbumin (PV), another calcium binding protein. PV is expressed in a subset of interneurons that innervate distinct domains of pyramidal cells (Klausberger et al., 2003; Somogyi and Klausberger, 2005) , promoting a highly coordinated input integration of these cells. We detected XRN2 and PAPD4 labeling in PV-positive cells in all regions Fig. 8 . XRN2 is virtually absent in astrocytes from the developing and adult hippocampi. To verify the presence of XRN2 immunolabeling (green) in astrocytes from the hippocampus, we performed double-labeling experiments on coronal sections of P5 and P60 hippocampi using anti-glial fibrillary acidic protein (GFAP, red), followed by counter-staining with DAPI (blue). analyzed in this study. After combining pixel intensity profiles and digital zooming followed by RGB decomposition data, we indicated that XRN2 (Figs. 12, In immature neurons, miRNA biosynthesis follows a well-described process. In the nucleus, pri-miRNA interacts with Drosha and DGCR8, resulting in its editing to pre-miRNA. This hairpin molecule is translocated into cytosol with the participation of Exportin-5. In the cytosol, pre-miRNA is cleaved by DICER and its RNA binding protein TRBP for final processing into mature miRNAs. One strand is selected for stable association with Argonaute (Ago2), and this strand serves as a guide to target and regulate specific mRNAs in the RISC complex. Based on our results, PAPD4 is mainly located in the cytoplasmic compartment in immature principal neurons from the hippocampus. Therefore, PAPD4 may be involved in the addition of adenine to the 3′-end of pre-miRNA and miRNA, stabilizing these molecules in the cytoplasm. (C) Representation of a mature pyramidal cell. (D) XRN2 levels are higher in the nucleus of mature neurons than in immature neurons. Thus, XRN2 may be involved in the cleavage of miRNA precursors in differentiated neurons. This results in PAPD4 translocation into the nucleus and in the stabilization of miRNA precursors during development.
when the same analysis was performed for PAPD4, we observed a change in PAPD4 labeling in PV-positive and -negative cells (1.56 ± 0.2 vs. 0.75 ± 0.08, P b 0.01). Taken together, these results revealed accumulation of PAPD4 in PV-positive interneurons.
Discussion
The control of gene expression in neurons has to be finely regulated, considering that these cells operate under a wide variety of conditions. In the nervous system, control of gene expression by miRNAs has been investigated in several, distinct, physiological processes (Cao et al., 2006; Vreugdenhil and Berezikov, 2010) . Recent studies have indicated that the specificity of these short nucleotide sequences for particular mRNAs follows a probabilistic, rather than a deterministic approach (Ragan et al., 2011) . Consequently, specificity of miRNA relatedactivity on target genes depends on intracellular concentrations, which in turn depends on the balance between biosynthesis and degradation (Kai and Pasquinelli, 2010) .
In this study, we reported the expression of newly investigated genes XRN2 and PAPD4 in the hippocampus. XRN2 is involved in the extinction of miRNA activity rather than in the clearance of inactive miRNAs (Chatterjee and Grosshans, 2009 ). In contrast, PAPD4 is a regulatory cytoplasmic poly(A) polymerase responsible for the 3′-terminal adenylation of pre-miRNA and miRNA (Katoh et al., 2009 ). Based on our results, XRN2 and PAPD4 accumulate in the same cells, although regulation of this process is unlikely because of common transcription factors. This finding implies that post-transcriptional mechanisms may control the presence of both proteins. Because the transcript levels of XRN and PAPD4 are higher and uniform, respectively, during development compared with the adult, we hypothesize that miRNAs may control the translational rate of both genes. Regardless of the precise mechanism underlying this process, we cope with a rare, singular circumstance in biology: a coincident, almost complete intersected expression of functionally-opposed genes, reinforcing that their antagonistically driven actions "make sense" if simultaneously present at the same cells (Burt and Trivers, 2008; Rowland and Peeper, 2006) .
Based on our results, we propose a possible new mechanism that controls miRNA expression. We are confident that immature (Figs. 13, A-B) and mature (Figs. 13, neurons are the only cell types in the central nervous system to exhibit such a mechanism, and this conclusion is based on the antagonist-driven actions of XRN2 and PAPD4.
Taking into account the roles attributed to miRNAs in cell differentiation (Andersson et al., 2010; Decembrini et al., 2009; Gao, 2008; Li et al., 2011; Zheng et al., 2010) , it was surprising that both XRN2 and PAPD4 were not expressed by neuronal progenitor cells. In contrast, the presence of both proteins in the same hippocampal neurons depicts how gene expression in neuronal function is finely and specifically adjusted depending on the ensuing physiological process. In agreement with our results, recent studies have demonstrated that translational control of mRNAs in dendrites is essential for certain types of synaptic plasticity such as learning and memory (Lee et al., 2012; Udagawa et al., 2012) . Despite this, control of gene expression in specific cells during physiological conditions remains puzzling because of the specific neuronal wiring in the hippocampus. Therefore, regulation of the transcriptome should be examined on the basis of particular micro-circuitry-related roles. In this study, we determined that specific neuronal subtypes, namely CR-and PV-positive interneurons, differentially accumulate XRN2 and PAPD4, indicating a unique balance between miRNA degradation and stabilization in these cells. Considering the roles of CR-and PVpositive interneurons in inhibitory circuits (Markram et al., 2004; Zaitsev et al., 2005) , it seems feasible that these cells exhibit refined regulatory mechanisms of the transcriptome in developing and mature hippocampus. The regulation of synaptic activity has been associated with fast, prompt mechanisms and involves the participation of miRNAs since neuronal activity rapidly induces the transcription of specific miRNAs such as CREB-regulated miRNA-132 (Nudelman et al., 2010 ).
In addition, recent reports describe the critical role of PV-positive interneurons in hippocampal synchrony, spatial representations, and working memory (Korotkova et al., 2010) . In conclusion, it is believed that XRN2 and PAPD4 are involved in a mechanism that controls miRNArelated activities in the nervous system.
